OCUL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Ocular Therapeutix Inc (OCUL).


$1.34B Market Cap.

As of 03/03/2025 5:00 PM ET (MRY) • Disclaimer

OCUL Market Cap. (MRY)


OCUL Shares Outstanding (MRY)


OCUL Assets (MRY)


Total Assets

$457.94M

Total Liabilities

$142.59M

Total Investments

$0

OCUL Income (MRY)


Revenue

$63.72M

Net Income

-$193.51M

Operating Expense

$229.88M

OCUL Cash Flow (MRY)


CF Operations

-$134.68M

CF Investing

-$1.29M

CF Financing

$332.11M

OCUL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

OCUL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$457,935,000 (81.68%)

$252,060,000 (68.84%)

$149,289,000 (-27.14%)

$204,887,000 (-21.76%)

Assets Current

$440,987,000 (89.89%)

$232,235,000 (79.16%)

$129,627,000 (-32.24%)

$191,300,000 (-22.29%)

Assets Non-Current

$16,948,000 (-14.51%)

$19,825,000 (0.83%)

$19,662,000 (44.71%)

$13,587,000 (-13.48%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$315,344,000 (246.03%)

$91,131,000 (157.59%)

$35,379,000 (-59.80%)

$87,999,000 (15.64%)

Property Plant & Equipment Net

$15,334,000 (-15.80%)

$18,211,000 (1.75%)

$17,898,000 (51.38%)

$11,823,000 (-15.18%)

Cash & Equivalents

$393,716,000 (99.28%)

$197,571,000 (89.86%)

$104,064,000 (-37.28%)

$165,928,000 (-27.80%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$14,128,000 (-1.82%)

$14,390,000 (3.06%)

$13,963,000 (7.41%)

$13,000,000 (8.33%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$3,040,000 (31.89%)

$2,305,000 (16.77%)

$1,974,000 (57.92%)

$1,250,000 (4.08%)

Trade & Non-Trade Receivables

$32,388,000 (23.72%)

$26,179,000 (22.76%)

$21,325,000 (0.90%)

$21,135,000 (72.50%)

Trade & Non-Trade Payables

$4,176,000 (-4.85%)

$4,389,000 (-14.33%)

$5,123,000 (11.56%)

$4,592,000 (69.51%)

Accumulated Retained Earnings (Deficit)

-$891,084,000 (-27.74%)

-$697,578,000 (-13.09%)

-$616,842,000 (-13.02%)

-$545,804,000 (-1.22%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$75,783,000 (-9.12%)

$83,389,000 (29.72%)

$64,283,000 (8.99%)

$58,983,000 (0.93%)

Debt Current

$1,933,000 (21.88%)

$1,586,000 (-0.81%)

$1,599,000 (-1.54%)

$1,624,000 (-83.17%)

Debt Non-Current

$73,850,000 (-9.72%)

$81,803,000 (30.50%)

$62,684,000 (9.28%)

$57,359,000 (17.56%)

Total Liabilities

$142,591,000 (-11.40%)

$160,929,000 (41.28%)

$113,910,000 (-2.55%)

$116,888,000 (-37.08%)

Liabilities Current

$41,354,000 (18.51%)

$34,896,000 (11.15%)

$31,395,000 (19.20%)

$26,337,000 (-1.23%)

Liabilities Non-Current

$101,237,000 (-19.67%)

$126,033,000 (52.74%)

$82,515,000 (-8.87%)

$90,551,000 (-43.09%)

OCUL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$63,723,000 (9.03%)

$58,443,000 (13.49%)

$51,494,000 (18.32%)

$43,522,000 (150.08%)

Cost of Revenue

$5,626,000 (6.53%)

$5,281,000 (16.32%)

$4,540,000 (3.04%)

$4,406,000 (111.52%)

Selling General & Administrative Expense

$102,243,000 (37.26%)

$74,489,000 (3.25%)

$72,146,000 (7.57%)

$67,070,000 (35.57%)

Research & Development Expense

$127,635,000 (109.05%)

$61,055,000 (14.20%)

$53,462,000 (6.75%)

$50,083,000 (74.54%)

Operating Expenses

$229,878,000 (69.60%)

$135,544,000 (7.91%)

$125,608,000 (7.22%)

$117,153,000 (49.88%)

Interest Expense

$13,577,000 (19.75%)

$11,338,000 (61.46%)

$7,022,000 (5.26%)

$6,671,000 (-1.43%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$193,506,000 (-139.68%)

-$80,736,000 (-13.65%)

-$71,038,000 (-984.05%)

-$6,553,000 (95.79%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$193,506,000 (-139.68%)

-$80,736,000 (-13.65%)

-$71,038,000 (-984.05%)

-$6,553,000 (95.79%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$193,506,000 (-139.68%)

-$80,736,000 (-13.65%)

-$71,038,000 (-984.05%)

-$6,553,000 (95.79%)

Weighted Average Shares

$158,265,162 (98.26%)

$79,827,362 (3.84%)

$76,875,035 (0.63%)

$76,392,870 (25.74%)

Weighted Average Shares Diluted

$158,265,162 (84.90%)

$85,596,594 (3.57%)

$82,644,267 (0.59%)

$82,162,102 (35.24%)

Earning Before Interest & Taxes (EBIT)

-$179,929,000 (-159.27%)

-$69,398,000 (-8.41%)

-$64,016,000 (-54350.85%)

$118,000 (100.08%)

Gross Profit

$58,097,000 (9.28%)

$53,162,000 (13.22%)

$46,954,000 (20.04%)

$39,116,000 (155.33%)

Operating Income

-$171,781,000 (-108.52%)

-$82,382,000 (-4.74%)

-$78,654,000 (-0.79%)

-$78,037,000 (-24.17%)

OCUL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,288,000 (78.84%)

-$6,087,000 (-63.85%)

-$3,715,000 (-211.14%)

-$1,194,000 (-41.97%)

Net Cash Flow from Financing

$332,110,000 (95.56%)

$169,828,000 (11580.06%)

$1,454,000 (-49.00%)

$2,851,000 (-98.75%)

Net Cash Flow from Operations

-$134,677,000 (-91.75%)

-$70,234,000 (-17.84%)

-$59,603,000 (9.07%)

-$65,550,000 (-22.40%)

Net Cash Flow / Change in Cash & Cash Equivalents

$196,145,000 (109.77%)

$93,507,000 (251.15%)

-$61,864,000 (3.18%)

-$63,893,000 (-136.80%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,288,000 (78.84%)

-$6,087,000 (-63.85%)

-$3,715,000 (-211.14%)

-$1,194,000 (-41.97%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$51,165,000 (0%)

$0 (0%)

-$445,000 (0%)

Issuance (Purchase) of Equity Shares

$332,110,000 (179.88%)

$118,663,000 (8061.14%)

$1,454,000 (-59.28%)

$3,571,000 (-98.43%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$33,109,000 (85.74%)

$17,825,000 (5.08%)

$16,964,000 (13.27%)

$14,977,000 (98.87%)

Depreciation Amortization & Accretion

$3,786,000 (26.92%)

$2,983,000 (41.44%)

$2,109,000 (-12.89%)

$2,421,000 (-12.69%)

OCUL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

91.20% (0.22%)

91.00% (-0.22%)

91.20% (1.45%)

89.90% (2.16%)

Profit Margin

-303.70% (-119.91%)

-138.10% (-0.07%)

-138.00% (-813.91%)

-15.10% (98.31%)

EBITDA Margin

-276.40% (-143.31%)

-113.60% (5.49%)

-120.20% (-2172.41%)

5.80% (100.69%)

Return on Average Equity (ROAE)

-53.30% (81.55%)

-288.90% (-130.94%)

-125.10% (-1524.68%)

-7.70% (99.18%)

Return on Average Assets (ROAA)

-38.60% (20.41%)

-48.50% (-14.12%)

-42.50% (-1365.52%)

-2.90% (97.48%)

Return on Sales (ROS)

-282.40% (-137.91%)

-118.70% (4.51%)

-124.30% (-41533.33%)

0.30% (100.04%)

Return on Invested Capital (ROIC)

-178.10% (-137.47%)

-75.00% (14.97%)

-88.20% (-44200.00%)

0.20% (100.09%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-7 (-58.51%)

-4.42 (-44.60%)

-3.05 (96.06%)

-77.44 (-857.75%)

Price to Sales Ratio (P/S)

21.21 (248.16%)

6.09 (45.22%)

4.2 (-65.71%)

12.23 (-83.07%)

Price to Book Ratio (P/B)

4.26 (9.54%)

3.89 (-36.46%)

6.12 (0.81%)

6.07 (-68.75%)

Debt to Equity Ratio (D/E)

0.45 (-74.41%)

1.77 (-45.16%)

3.22 (142.47%)

1.33 (-45.60%)

Earnings Per Share (EPS)

-1.22 (-20.79%)

-1.01 (-9.78%)

-0.92 (-922.22%)

-0.09 (96.48%)

Sales Per Share (SPS)

0.4 (-44.95%)

0.73 (9.25%)

0.67 (17.54%)

0.57 (99.30%)

Free Cash Flow Per Share (FCFPS)

-0.86 (10.15%)

-0.96 (-16.02%)

-0.82 (5.72%)

-0.87 (2.35%)

Book Value Per Share (BVPS)

1.99 (74.52%)

1.14 (148.26%)

0.46 (-60.07%)

1.15 (-8.06%)

Tangible Assets Book Value Per Share (TABVPS)

2.89 (-8.39%)

3.16 (62.62%)

1.94 (-27.59%)

2.68 (-37.77%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (0.00%)

-5 (-150.00%)

-2 (-100.06%)

3,489 (34990.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-5.61 (-14.76%)

-4.89 (-97.42%)

-2.48 (-101.53%)

162.13 (1718.43%)

Asset Turnover

0.13 (-63.82%)

0.35 (13.96%)

0.31 (58.76%)

0.19 (50.39%)

Current Ratio

10.66 (60.24%)

6.66 (61.18%)

4.13 (-43.16%)

7.26 (-21.32%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$135,965,000 (-78.15%)

-$76,321,000 (-20.54%)

-$63,318,000 (5.13%)

-$66,744,000 (-22.70%)

Enterprise Value (EV)

$988,926,827 (204.37%)

$324,911,072 (111.83%)

$153,383,182 (-62.74%)

$411,658,766 (-71.87%)

Earnings Before Tax (EBT)

-$193,506,000 (-139.68%)

-$80,736,000 (-13.65%)

-$71,038,000 (-984.05%)

-$6,553,000 (95.79%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$176,143,000 (-165.22%)

-$66,415,000 (-7.28%)

-$61,907,000 (-2538.24%)

$2,539,000 (101.74%)

Invested Capital

$98,648,000 (-4.21%)

$102,982,000 (31.84%)

$78,113,000 (9.09%)

$71,605,000 (12.20%)

Working Capital

$399,633,000 (102.51%)

$197,339,000 (100.89%)

$98,232,000 (-40.45%)

$164,963,000 (-24.84%)

Tangible Asset Value

$457,935,000 (81.68%)

$252,060,000 (68.84%)

$149,289,000 (-27.14%)

$204,887,000 (-21.76%)

Market Capitalization

$1,342,636,827 (279.05%)

$354,207,072 (63.68%)

$216,399,182 (-59.47%)

$533,972,766 (-63.87%)

Average Equity

$363,260,750 (1199.89%)

$27,945,500 (-50.80%)

$56,801,500 (-32.98%)

$84,748,500 (408.59%)

Average Assets

$501,085,500 (201.14%)

$166,393,750 (-0.45%)

$167,140,250 (-25.41%)

$224,093,250 (65.93%)

Invested Capital Average

$101,013,250 (9.12%)

$92,570,750 (27.58%)

$72,558,500 (4.79%)

$69,242,750 (4.43%)

Shares

157,217,427 (97.96%)

79,418,626 (3.13%)

77,010,385 (0.52%)

76,610,153 (7.31%)